In an adult, what hemoglobin A1c (HbA1c) cut‑off values define prediabetes and type 2 diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

HbA1c Cut Points for Prediabetes and Type 2 Diabetes

In adults, prediabetes is defined as HbA1c 5.7–6.4% (39–47 mmol/mol), and type 2 diabetes is diagnosed at HbA1c ≥6.5% (≥48 mmol/mol). 1

Diagnostic Thresholds

Prediabetes: HbA1c 5.7–6.4%

The American Diabetes Association establishes the prediabetes range at 5.7% to 6.4% 1, 2, 1. This range identifies individuals at substantially increased risk for progression to diabetes:

  • HbA1c 5.5–6.0%: 5-year diabetes incidence of 9–25%
  • HbA1c 6.0–6.5%: 5-year diabetes incidence of 25–50%, with a relative risk 20 times higher than HbA1c of 5.0% 1

The 5.7% lower threshold was specifically chosen because it identifies individuals with diabetes risk similar to high-risk participants in the Diabetes Prevention Program, making them ideal candidates for intensive lifestyle intervention 1, 3.

Type 2 Diabetes: HbA1c ≥6.5%

Type 2 diabetes is diagnosed at HbA1c ≥6.5% (≥48 mmol/mol) 1, 2, 1. This threshold should be confirmed with repeat testing unless the patient presents with unequivocal hyperglycemia or hyperglycemic crisis 4.

Important Clinical Considerations

Risk Continuum

Risk is continuous across all HbA1c values, extending below the lower limit of the prediabetes range and becoming disproportionately greater at the higher end 1, 2, 1. This means:

  • Individuals with HbA1c >6.0% warrant more aggressive intervention and closer follow-up
  • Those with both elevated HbA1c and abnormal fasting glucose represent the highest-risk group requiring immediate action

International Variation

The World Health Organization and some international organizations define prediabetes starting at HbA1c 6.0% rather than 5.7% 1. However, the ADA's 5.7% threshold captures more individuals who would benefit from early intervention, particularly for lifestyle modification programs 5, 6.

Confirmation Testing

When HbA1c results are discordant with other glucose measures, repeat the test that exceeded the diagnostic threshold. If two different tests both exceed their respective thresholds (e.g., both HbA1c ≥6.5% and fasting glucose ≥126 mg/dL), diabetes is confirmed without additional testing 4.

Testing Limitations

HbA1c may be unreliable in certain conditions affecting red blood cell turnover, including hemoglobinopathies, recent blood loss, hemolytic anemia, or pregnancy 3. In these situations, use glucose-based criteria instead.

Screening Frequency

For adults with normal test results, repeat screening at minimum 3-year intervals. More frequent testing is appropriate when BMI is increasing or risk factors are worsening 1.

Related Questions

For a 21-year-old male with stress‑related recurrent shaking episodes and mild occipital headache, normal laboratory studies and a normal CT scan, and prediabetes (hemoglobin A1c 5.8%), is the current impression and plan appropriate and what management should be recommended for his headache and shaking?
Is an HbA1c of 6.4% considered pre‑diabetes?
Does a hemoglobin A1c of 5.6% indicate prediabetes?
Is a hemoglobin A1c (HbA1c) of 5.5% indicative of prediabetes?
What is the appropriate management for an otherwise healthy adult with a fasting blood glucose of 107 mg/dL and an HbA1c of 5.26%?
In a 75-year-old man with an indwelling urinary catheter for benign prostatic hyperplasia who is asymptomatic but has a urine culture growing Klebsiella (>10⁵ CFU/mL) susceptible to ciprofloxacin, amikacin, and co‑trimoxazole, should antimicrobial therapy be started or is the appropriate management simply to proceed with the scheduled catheter change?
Should I switch from 10 mg immediate‑release Adderall (mixed amphetamine salts) to an extended‑release formulation to achieve full‑day symptom control?
What is the recommended treatment for periodic limb movements occurring in both non‑rapid eye movement (NREM) and rapid eye movement (REM) sleep, not associated with respiratory events, with elevated muscle tone observed during REM?
What is the diagnosis and recommended next step for a patient with right thumb pain after a fall, exhibiting approximately 30° increased laxity at the metacarpophalangeal (MCP) joint compared to the left thumb, no fixed point of motion, and pain worsened by gripping the steering wheel or moving the thumb?
What are the recommended dosing regimens for doxepin in adults for insomnia and depression, including starting doses, titration steps, maximum doses, and adjustments for patients over 65 years or with hepatic impairment?
How can I justify transferring a patient who experienced ventricular fibrillation during cardiac catheterization (without ventricular engagement, requiring cardioversion) and now has multiple symptomatic long runs of non‑sustained ventricular tachycardia while on amiodarone and wearing a LifeVest to a tertiary electrophysiology (EP) center for an EP study?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.